Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2025-12-24 @ 10:01 PM
NCT ID:
NCT00822432
Eligibility Criteria:
Inclusion criteria :
* Patients receiving HDMTX (≥1g/m2) for a primitive cerebral lymphoma, a large cell lymphoma, a lymphoblastic lymphoma, a Burkitt's lymphoma or an acute lymphoblastic leukaemia,
* over 18 years old,
* Signed informed consent.
* Affiliated to a medical assurance.
* Able to respect the protocol.
* Effective contraception for women.
Exclusion criteria :
* renal failure,
* liver failure,
* hepatic cytolysis,
* chronic respiratory deficiency,
* pregnancy,
* breast-feeding,
* Concomitant medication: phenytoin, probenecid, trimethoprim, phenylbutazone, salicylates, non steroid anti-inflammatory, yellow fever vaccine.
* Patient included in another study in the four weeks preceding his inclusion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00822432
Study Brief:
Protocol Section:
NCT00822432